WAM
PDLI

World Asset Management’s PDL BioPharma, Inc. PDLI Stock Holding History

World Asset Management’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-10,967
Closed -$87K – 1725
2013
Q3 		$87K Sell
10,967
-2,068
-16% -$16.6K ﹤0.01% 1650
2013
Q2 		$101K Buy
+13,035
New +$102K ﹤0.01% 1687

Other funds holding PDLI

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GAM
Gotham Asset Management New York $43B AUM 34.97% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return

World Asset Management's PDLI Position: Q4 2013 in Review

World Asset Management sold out of PDL BioPharma, Inc. (PDLI) in Q4 2013, closing a stake of 10,967 shares — an estimated $87K sold.

World Asset Management first reported a position in PDLI in Q2 2013 and held it in 2 quarters. The position peaked at $101K in Q2 2013. 224 funds tracked by Wall St. Rank hold PDLI as of Q4 2013.

  • World Asset Management reported no remaining PDL BioPharma, Inc. position as of Q4 2013 after selling out during the quarter.
  • World Asset Management sold 10,967 PDL BioPharma, Inc. shares in Q4 2013, an estimated $87K.
  • World Asset Management first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 2 quarters.
  • World Asset Management's PDL BioPharma, Inc. position peaked at $101K in Q2 2013.
  • 224 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2013.

Based on World Asset Management's 13F filing for Q4 2013, filed 24 Jan 2014.